Eupraxia Pharmaceuticals, Inc. (EPRX)
7.44
-0.01
(-0.13%)
USD |
NASDAQ |
Sep 03, 15:05
Eupraxia Pharmaceuticals Price : 7.44 for Sept. 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 6.40 | 7.47 | 6.33 | 7.45 | 749994.0 |
| Sep 01, 2026 | 6.46 | 6.53 | 6.33 | 6.34 | 151656.0 |
| Aug 31, 2026 | 6.67 | 6.855 | 6.33 | 6.46 | 370700.0 |
| Aug 28, 2026 | 7.38 | 7.447 | 6.665 | 6.675 | 174230.0 |
| Aug 27, 2026 | 7.42 | 7.53 | 7.30 | 7.36 | 208630.0 |
| Aug 26, 2026 | 7.37 | 7.47 | 7.24 | 7.43 | 235503.0 |
| Aug 25, 2026 | 7.31 | 7.46 | 7.13 | 7.42 | 562444.0 |
| Aug 24, 2026 | 6.75 | 7.38 | 6.64 | 7.28 | 1.356M |
| Aug 21, 2026 | 6.77 | 6.875 | 6.679 | 6.73 | 298005.0 |
| Aug 20, 2026 | 6.97 | 7.04 | 6.69 | 6.76 | 176208.0 |
| Aug 19, 2026 | 6.93 | 7.090 | 6.80 | 7.01 | 395502.0 |
| Aug 18, 2026 | 6.81 | 6.88 | 6.715 | 6.85 | 379171.0 |
| Aug 17, 2026 | 6.72 | 6.89 | 6.65 | 6.82 | 127282.0 |
| Aug 14, 2026 | 6.66 | 6.72 | 6.46 | 6.72 | 164661.0 |
| Aug 13, 2026 | 6.70 | 6.87 | 6.495 | 6.67 | 255902.0 |
| Aug 12, 2026 | 6.79 | 6.79 | 6.41 | 6.48 | 220928.0 |
| Aug 11, 2026 | 6.67 | 6.86 | 6.66 | 6.70 | 181021.0 |
| Aug 10, 2026 | 6.77 | 6.885 | 6.66 | 6.66 | 270220.0 |
| Aug 07, 2026 | 6.84 | 6.87 | 6.57 | 6.77 | 475865.0 |
| Aug 06, 2026 | 6.43 | 6.71 | 6.40 | 6.66 | 199719.0 |
| Aug 05, 2026 | 6.57 | 6.70 | 6.44 | 6.48 | 100393.0 |
| Aug 04, 2026 | 6.40 | 6.645 | 6.36 | 6.52 | 258772.0 |
| Aug 03, 2026 | 6.40 | 6.68 | 6.325 | 6.51 | 98558.00 |
| Jul 31, 2026 | 6.55 | 6.74 | 6.15 | 6.40 | 457159.0 |
| Jul 30, 2026 | 6.01 | 6.60 | 5.975 | 6.55 | 1.104M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Edesa Biotech, Inc. | 4.84 |
| ProMIS Neurosciences, Inc. | 12.77 |
| Arrowhead Pharmaceuticals, Inc. | 85.84 |
| Oncolytics Biotech, Inc. | 0.855 |
| Sangamo Therapeutics, Inc. | 0.171 |
Price Related Metrics
| PEG Ratio | -0.4601 |
| Price to Book Value | 4.787 |
| Earnings Yield | -13.23% |
| Market Cap | 487.13M |
| PEGY Ratio | -0.4601 |